Edgewell Personal Care Company (EPC) — Fair Value Analysis
Base-case fair value (P50): $20.55 · Current price: $27.21 · Verdict: Overvalued
The Verdict on EPC
Based on our Monte Carlo simulations, EDGEWELL PERSONAL CARE (EPC) appears Overvalued at its current market price of $27.21. Our analysis indicates a median fair value (P50) of $20.55, suggesting a potential -24.5% downside from its present trading level. This assessment stems from thousands of forward-looking scenarios, which consistently point to a lower intrinsic value for EPC compared to its market capitalization. Investors should note this significant discrepancy between the current price and the model's central fair value estimate.
How EPC stacks up against peers
EPC's quality tier is currently categorized as "weak," reflecting challenges in its operational and financial health when compared against sector peers. This weak standing further underpins the overvaluation verdict, as the Monte Carlo simulations incorporate these fundamental health metrics into their probability distributions. The current trading price of $27.21 does not seem to adequately account for these underlying weaknesses, demanding a closer look from investors. The median fair value of $20.55 provides a more realistic anchor based on these comparative metrics and simulated future performance.
What this means for investors
The pronounced -24.5% gap between EPC's $27.21 and its median fair value of $20.55 suggests that the stock carries elevated risk for long-term holders. Given the "weak" quality tier, the market may be overestimating EPC's future earnings potential or failing to fully price in operational hurdles. Investors should exercise caution, as the current market price implies a significantly higher valuation than what our robust Monte Carlo analysis supports. Understanding the full range of potential outcomes, including both downside and bull case scenarios, is critical. Sign up for FairCurve to see the full bear/bull distribution and track EPC's fair value as new fundamentals are released.
Frequently Asked Questions
Is EPC overvalued or undervalued right now?
Based on our Monte Carlo simulations, EDGEWELL PERSONAL CARE (EPC) is overvalued. Its current price of $27.21 is significantly above our median fair value estimate (P50) of $20.55.
What is the bear case and bull case for EPC?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices, along with the probability of upside, is available with a free FairCurve account. We do not provide specific dollar values here as they are gated for subscribers.
How does FairCurve calculate EPC's fair value?
FairCurve calculates EPC's fair value using sophisticated Monte Carlo simulations, running thousands of forward-looking scenarios to determine a probability distribution of potential intrinsic values. This provides a robust estimate for the median fair value (P50).
How can I track EPC's fair value as it changes?
You can add EPC to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation whenever new earnings are released. This ensures you always have the most current assessment based on fresh fundamental data.